307 related articles for article (PubMed ID: 33667046)
1. [Acromegaly and it's cardiovascular implications].
Cadena-Obando DA; Remba-Shapiro I; Abreu-Rosario CG; Mercado M
Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):73-80. PubMed ID: 33667046
[TBL] [Abstract][Full Text] [Related]
2. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
3. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
4. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
[TBL] [Abstract][Full Text] [Related]
5. A case of juvenile acromegaly that was initially diagnosed as severe congestive heart failure from acromegaly-induced dilated cardiomyopathy.
Sue M; Yoshihara A; Okubo Y; Ishikawa M; Ando Y; Hiroi N; Shibuya K; Yoshino G
Intern Med; 2010; 49(19):2117-21. PubMed ID: 20930439
[TBL] [Abstract][Full Text] [Related]
6. Acromegaly in the elderly patients.
Ambrosio MR; Gagliardi I; Chiloiro S; Ferreira AG; Bondanelli M; Giampietro A; Bianchi A; Marinis L; Fleseriu M; Zatelli MC
Endocrine; 2020 Apr; 68(1):16-31. PubMed ID: 32060689
[TBL] [Abstract][Full Text] [Related]
7. [Acromegaly and pregnancy: report of six new cases].
Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
[TBL] [Abstract][Full Text] [Related]
8. Acromegaly.
Chanson P; Salenave S; Kamenicky P
Handb Clin Neurol; 2014; 124():197-219. PubMed ID: 25248589
[TBL] [Abstract][Full Text] [Related]
9. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
Schwyzer L; Starke RM; Jane JA; Oldfield EH
J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
[TBL] [Abstract][Full Text] [Related]
10. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
11. Acromegalic Cardiomyopathy: An Entity on its own? The Effects of GH and IGF-I Excess and Treatment on Cardiovascular Risk Factors.
Wolf P; Maione L; Kamenický P; Chanson P
Arch Med Res; 2023 Dec; 54(8):102921. PubMed ID: 38040526
[TBL] [Abstract][Full Text] [Related]
12. Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism.
Bondanelli M; Bonadonna S; Ambrosio MR; Doga M; Gola M; Onofri A; Zatelli MC; Giustina A; degli Uberti EC
Metabolism; 2005 Sep; 54(9):1174-80. PubMed ID: 16125529
[TBL] [Abstract][Full Text] [Related]
13. Ectopic GH-secreting pituitary adenoma of the clivus: systematic literature review of a challenging tumour.
Riccio L; Donofrio CA; Tomacelli G; De Blasi R; Melatini A
Pituitary; 2020 Aug; 23(4):457-466. PubMed ID: 32504302
[TBL] [Abstract][Full Text] [Related]
14. The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study.
Varadhan L; Reulen RC; Brown M; Clayton RN
Pituitary; 2016 Jun; 19(3):251-61. PubMed ID: 26724807
[TBL] [Abstract][Full Text] [Related]
15. [Current diagnosis and treatment of acromegaly].
Melgar V; Espinosa E; Cuenca D; Valle V; Mercado M
Rev Med Inst Mex Seguro Soc; 2015; 53(1):74-83. PubMed ID: 25680646
[TBL] [Abstract][Full Text] [Related]
16. 'Silent' somatotropinoma.
Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
[TBL] [Abstract][Full Text] [Related]
17. Growth Hormone Excess: Implications and Management.
Dhaneshwar S; Shandily S; Tiwari V
Endocr Metab Immune Disord Drug Targets; 2023; 23(6):748-763. PubMed ID: 36237164
[TBL] [Abstract][Full Text] [Related]
18. [Not Available].
Mosbah H; Brue T; Chanson P
Ann Endocrinol (Paris); 2019 Sep; 80 Suppl 1():S10-S18. PubMed ID: 31606057
[TBL] [Abstract][Full Text] [Related]
19. Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide.
Puglisi S; Ferraù F; Ragonese M; Spagnolo F; Cannavò S
Front Endocrinol (Lausanne); 2020; 11():28. PubMed ID: 32117056
[TBL] [Abstract][Full Text] [Related]
20. Sleep apnea and cardiovascular complications of the acromegaly. Response to the medical treatment.
García-Álvarez M; Climent V
Minerva Endocrinol; 2019 Jun; 44(2):159-168. PubMed ID: 30482010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
